Dr. Hiba Moukadem, medical oncologist and breast cancer specialist at the American University of Beirut Medical Center, reviews results from two key Presidential Session abstracts at ESMO 2025 — DESTINY-Breast05 and DESTINY-Breast11 — and their clinical implications.
